Oxidative stress is associated with migraine and migraine-related metabolic risk in females

European Journal of Neurology

Volumn 18, Issue 10, 2011, Pages 1233-1239

  Bernecker, C ^a   Ragginer, C ^a   Fauler, G ^a   Horejsi, R ^a   Moller R ^a   Zelzer, S ^a   Lechner, A ^a   Wallner Blazek, M ^a   Weiss, S ^a   Fazekas, F ^a   Bahadori, B ^b   Truschnig Wilders, M ^a   Gruber, H J ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b State Clinic St Poelten   (Austria)

Author keywords

4 hydroxy 2 nonenal; Malondialdehyde; Migraine; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; MALONALDEHYDE; NITRIC OXIDE;

ADULT; ARTICLE; ATHEROGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GLUCOSE METABOLISM; HUMAN; HYPERINSULINEMIA; INSULIN METABOLISM; LIPID METABOLISM; LOGISTIC REGRESSION ANALYSIS; MIGRAINE; NITROSATIVE STRESS; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CARBONYLATION; RISK;

ADULT; COHORT STUDIES; FEMALE; HUMANS; INFLAMMATION; LIPID METABOLISM; MIDDLE AGED; MIGRAINE DISORDERS; OXIDATIVE STRESS; RISK FACTORS; SEX CHARACTERISTICS;

EID: 80052811122     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03414.x     Document Type: Article

References (45)

1. Yilmaz G, Surer H, Inan LE, Coskun O, Yucel D. Increased nitrosative and oxidative stress in platelets of migraine patients. Tohoku J Exp Med 2007; 211: 23-30.
2. Bockowski L, Sobaniec W, Kulak W, Smigielska-Kuzia J. Serum and intraerythrocyte antioxidant enzymes and lipid peroxides in children with migraine. Pharmacol Rep 2008; 60: 542-548.
3. Gupta R, Pathak R, Bhatia MS, Banerjee BD. Comparison of oxidative stress among migraineurs, tension-type headache subjects, and a control group. Ann Indian Acad Neurol 2009; 12: 167-172.
4. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause, or consequence? Lancet 1994; 344: 721-724.
5. Tuncel D, Tolun FI, Gokce M, Imrek S, Ekerbicer H. Oxidative stress in migraine with and without aura. Biol Trace Elem Res 2008; 126: 92-97.
6. Gruber HJ, Bernecker C, Lechner A, et al. Increased nitric oxide stress is associated with migraine. Cephalalgia 2010; 30: 486-492.
7. Taffi R, Vignini A, Lanciotti C, et al. Platelet membrane fluidity and peroxynitrite levels in migraine patients during headache-free periods. Cephalalgia 2005; 25: 353-358.
8. Wei EP, Moskowitz MA, Boccalini P, Kontos HA. Calcitonin gene-related peptide mediates nitroglycerin and sodium nitroprusside-induced vasodilation in feline cerebral arterioles. Circ Res 1992; 70: 1313-1319.
9. Welch KM, Levine SR, D'Andrea G, Schultz LR, Helpern JA. Preliminary observations on brain energy metabolism in migraine studied by in vivo phosphorus 31 NMR spectroscopy. Neurology 1989; 39: 538-541.
10. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
11. Farooqui AA, Horrocks LA. Phospholipase A2-generated lipid mediators in the brain: the good, the bad, and the ugly. Neuroscientist 2006; 12: 245-260.
12. Trevisani M, Siemens J, Materazzi S, et al. 4-Hydroxynonenal, an endogenous aldehyde, causes pain and neurogenic inflammation through activation of the irritant receptor TRPA1. Proc Natl Acad Sci U S A 2007; 104: 13519-13524.
13. Catala A. Lipid peroxidation of membrane phospholipids generates hydroxy-alkenals and oxidized phospholipids active in physiological and/or pathological conditions. Chem Phys Lipids 2009; 157: 1-11.
14. Cavestro C, Rosatello A, Micca G, et al. Insulin metabolism is altered in migraineurs: a new pathogenic mechanism for migraine? Headache 2007; 47: 1436-1442.
15. Gruber HJ, Bernecker C, Pailer S, et al. Hyperinsulinaemia in migraineurs is associated with nitric oxide stress. Cephalalgia 2010; 30: 593-598.
16. Gruber HJ, Bernecker C, Pailer S, et al. Lipid profile in normal weight migraineurs - evidence for cardiovascular risk. Eur J Neurol 2010; 17: 419-425.
17. Rainero I, Limone P, Ferrero M, et al. Insulin sensitivity is impaired in patients with migraine. Cephalalgia 2005; 25: 593-597.
18. Houstis N, Rosen ED, Lander ES. Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006; 440: 944-948.
19. Muellenbach EA, Diehl CJ, Teachey MK, et al. Interactions of the advanced glycation end product inhibitor pyridoxamine and the antioxidant α -lipoic acid on insulin resistance in the obese Zucker rat. Metabolism 2008; 57: 1465-1472.
20. Song F, Jia W, Yao Y, et al. Oxidative stress, antioxidant status and DNA damage in patients with impaired glucose regulation and newly diagnosed Type 2 diabetes. Clin Sci (Lond) 2007; 112: 599-606.
21. Headache Classification Committee, International Headache Society. The international classification of headache disorders. 2nd edn. Cephalalgia 2004; 24: 1-160.
22. Luo XP, Yazdanpanah M, Bhooi N, Lehotay DC. Determination of aldehydes and other lipid peroxidation products in biological samples by gas chromatography-mass spectrometry. Anal Biochem 1995; 228: 294-298.
23. Pilz J, Meineke I, Gleiter CH. Measurement of free and bound malondialdehyde in plasma by high-performance liquid chromatography as the 2, 4-dinitrophenylhydrazine derivative. J Chromatogr B Biomed Sci Appl 2000; 742: 315-325.
24. Meinitzer A, Seelhorst U, Wellnitz B, et al. Asymmetrical dimethylarginine independently predicts total and cardiovascular mortality in individuals with angiographic coronary artery disease (the Ludwigshafen Risk and Cardiovascular Health study). Clin Chem 2007; 53: 273-283.
25. Catala A. The ability of melatonin to counteract lipid peroxidation in biological membranes. Curr Mol Med 2007; 7: 638-649.
26. Aruoma OI. Nutrition and health aspects of free radicals and antioxidants. Food Chem Toxicol 1994; 32: 671-683.
27. Halliwell B, Gutteridge JM. Role of free radicals and catalytic metal ions in human disease: an overview. Methods Enzymol 1990; 186: 1-85.
28. Awasthi YC, Yang Y, Tiwari NK, et al. Regulation of 4-hydroxynonenal-mediated signaling by glutathione S-transferases. Free Radic Biol Med 2004; 37: 607-619.
29. Ferrington DA, Kapphahn RJ. Catalytic site-specific inhibition of the 20S proteasome by 4-hydroxynonenal. FEBS Lett 2004; 578: 217-223.
30. Uchida K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog Lipid Res 2003; 42: 318-343.
31. Erol I, Alehan F, Aldemir D, Ogus E. Increased vulnerability to oxidative stress in pediatric migraine patients. Pediatr Neurol 2010; 43: 21-24.
32. Guldiken B, Demir M, Guldiken S, et al. Asymmetric dimethylarginine and nitric oxide levels in migraine during the interictal period. J Clin Neurosci 2009; 16: 672-674.
33. Gudmundsson LS, Aspelund T, Scher AI, et al. C-reactive protein in migraine sufferers similar to that of non-migraineurs: the Reykjavik Study. Cephalalgia 2009; 29: 1301-1310.
34. Kurth T, Ridker PM, Buring JE. Migraine and biomarkers of cardiovascular disease in women. Cephalalgia 2008; 28: 49-56.
35. Vanmolkot FH, de Hoon JN. Increased C-reactive protein in young adult patients with migraine. Cephalalgia 2007; 27: 843-846.
36. Welch KM, Brandes AW, Salerno L, Brandes JL. C-reactive protein may be increased in migraine patients who present with complex clinical features. Headache 2006; 46: 197-199.
37. Tietjen GE, Herial NA, White L, Utley C, Kosmyna JM, Khuder SA. Migraine and biomarkers of endothelial activation in young women. Stroke 2009; 40: 2977-2982.
38. Go YM, Halvey PJ, Hansen JM, Reed M, Pohl J, Jones DP. Reactive aldehyde modification of thioredoxin-1 activates early steps of inflammation and cell adhesion. Am J Pathol 2007; 171: 1670-1681.
39. Viigimaa M, Abina J, Zemtsovskaya G, et al. Malondialdehyde-modified low-density lipoproteins as biomarker for atherosclerosis. Blood Press 2010; 19: 164-168.
40. Yun MR, Im DS, Lee SJ et al. 4-hydroxynonenal contributes to macrophage foam cell formation through increased expression of class A scavenger receptor at the level of translation. Free Radic Biol Med 2008; 45: 177-183.
41. Mattson MP. Pathways towards and away from Alzheimer's disease. Nature 2004; 430: 631-639.
42. Pope SK, Shue VM, Beck C. Will a healthy lifestyle help prevent Alzheimer's disease? Annu Rev Public Health 2003; 24: 111-132.
43. Peterlin BL, Rapoport AM, Kurth T. Migraine and obesity: epidemiology, mechanisms, and implications. Headache 2010; 50: 631-648.
44. Peterlin BL, Rosso AL, Rapoport AM, Scher AI. Obesity and migraine: the effect of age, gender and adipose tissue distribution. Headache 2010; 50: 52-62.
45. Guldiken B, Guldiken S, Demir M, et al. Insulin resistance and high sensitivity C-reactive protein in migraine. Can J Neurol Sci 2008; 35: 448-451.